Insights into serotonin receptor trafficking: Cell membrane targeting and internalization

Progress in Molecular Biology and Translational Science

Volumn 132, Issue , 2015, Pages 97-126

  Darmon, Michèle ^a   Al Awabdh, Sana ^a   Emerit, Michel Boris ^a   Masson, Justine ^a  

^a CENTRE DE PSYCHIATRIE ET NEUROSCIENCES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GHRELIN RECEPTOR; SCAFFOLD PROTEIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR; CAVEOLIN; CYSTEINE; G PROTEIN COUPLED RECEPTOR; LIGAND; PROTEIN BINDING;

CELL MEMBRANE; CELL MEMBRANE TRANSPORT; CONFERENCE PAPER; DENDRITE; DIMERIZATION; EUKARYOTIC FLAGELLUM; HUMAN; INTERNALIZATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; ANIMAL; CENTRAL NERVOUS SYSTEM; CHEMISTRY; CHO CELL LINE; CRICETULUS; EMBRYOLOGY; ENDOCYTOSIS; GENETIC TRANSFECTION; HEK293 CELL LINE; HIPPOCAMPUS; METABOLISM; NERVE CELL; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT;

ANIMALS; CAVEOLINS; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; CHO CELLS; CRICETULUS; CYSTEINE; ENDOCYTOSIS; HEK293 CELLS; HIPPOCAMPUS; HUMANS; LIGANDS; NEURONS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, SEROTONIN; TRANSFECTION;

EID: 84942194965     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/bs.pmbts.2015.02.009     Document Type: Conference Paper

References (117)

1. Rapport MM, Green AA, Page IH. Crystalline serotonin. Science. 1948;108(2804): 329-330.
2. Amin AH, Crawford TBB, Gaddum JH. The distribution of substance P and serotonin in the central nervous system of the dog. J Physiol Lond. 1954;126:596-618.
3. Côté F, Thévenot E, Fligny C, et al. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci USA. 2003;100(23):13525-13530.
4. Hamon M, Bourgoin S, Artaud F, Glowinski J. The role of intraneuronal 5-HT and of tryptophan hydroxylase activation in the control of 5-HT synthesis in rat brain slices incubated in K+-enriched medium. J Neurochem. 1979;33(5):1031-1042.
5. Kühn DM, Wolf WA, Youdim MBH. Serotonin neurochemistry revisited: a new look at some old axioms. Neurochem Int. 1986;8:141-154.
6. Erickson JD, Eiden LE, Hoffman BJ. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA. 1992;89(22):10993-10997.
7. Liu Y, Peter D, Roghani A, et al. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell. 1992;70(4):539-551.
8. Schanberg SM. A study of the transport of 5-hydroxytryptophan and 5-hydroxytryptamine (serotonin) into brain. J Pharmacol Exp Ther. 1963;139:191-200.
9. Wong DT, Bymaster FP, Horng JS, Molloy BB. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-Methyl-3- phenylpropylamine. J Pharmacol Exp Ther. 1975;193(3):804-811.
10. Shaskan EG, Snyder SH. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J Pharmacol Exp Ther. 1970;175(2):404-418.
11. Shore PA, Mead JA, Kuntzman RG, Spector S, Brodie BB. On the physiologic significance of monoamine oxidase in brain. Science. 1957;126(3282):1063-1064.
12. Jouvet M, Bobillier P, Pujol JF, Renault J. Suppression of sleep and decrease of cerebral serotonin caused by lesion of the raphe system in the cat. C R Acad Sci Hebd Seances Acad Sci D. 1967;264(2):360-362.
13. Brittain RT, Handley SL. Temperature changes produced by the injection of catecholamines and 5-hydroxytryptamine into the cerebral ventricles of the conscious mouse. J Physiol. 1967;192(3):805-813.
14. Fuxe K, Farnebo LO, Hamberger B, Ogren SO. On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine. Postgrad Med J. 1975;51(suppl 1):35-45.
15. Sparkes CG, Spencer PS. Antinociceptive activity of morphine after injection of biogenic amines in the cerebral ventricles of the conscious rat. Br J Pharmacol. 1971;42(2):230-241.
16. Graham JR. Methysergide for prevention of headache: experience in five hundred patients over three years. N Engl J Med. 1964;270:67-72.
17. Laguzzi R, Reis DJ, Talman WT. Modulation of cardiovascular and electrocortical activity through serotonergic mechanisms in the nucleus tractus solitarius of the rat. Brain Res. 1984;304(2):321-328.
18. Ahlenius S, Larsson K, Svensson L. Further evidence for an inhibitory role of central 5-HT in male rat sexual behavior. Psychopharmacology (Berl). 1980;68(3):217-220.
19. Meyerson BJ, Lewander T. Serotonin synthesis inhibition and estrous behavior in female rats. Life Sci I. 1970;9(12):661-671.
20. Mabry PD, Campbell BA. Serotonergic inhibition of catecholamine-induced behavioral arousal. Brain Res. 1973;49(2):381-391.
21. Domeney AM, Costall B, Gerrard PA, Jones DN, Naylor RJ, Tyers MB. The effect of ondansetron on cognitive performance in the marmoset. Pharmacol Biochem Behav. 1991;38(1):169-175.
22. Thiebot MH. Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines? Pharmacol Biochem Behav. 1986;24(5):1471-1477.
23. Kasper S, Fuger J, Moller HJ. Comparative efficacy of antidepressants. Drugs. 1992;43- (suppl 2):11-22, discussion 22-13.
24. Peroutka SJ. Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol Psychiatry. 1985;20(9):971-979.
25. Meltzer HY. Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci. 1995;3(2):64-75.
26. Roth BL, Craigo SC, Choudhary MS, et al. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994;268(3):1403-1410.
27. Nelson DL, Herbet A, Bourgoin S, Glowinski J, Hamon M. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7- dihydroxytryptamine administration in the rat. Mol Pharmacol. 1978;14(6):983-995.
28. Lanfumey L, Hamon M. Central 5-HT(1A) receptors: regional distribution and functional characteristics. Nucl Med Biol. 2000;27(5):429-435.
29. Gray L, Scarr E, Dean B. Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorder. Psychiatry Res. 2006;143(2-3):111-120.
30. Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedebergs Arch Pharmacol. 1995;352(2):141-148.
31. Riad M, Watkins KC, Doucet E, Hamon M, Descarries L. Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J Neurosci. 2001;21(21):8378-8386.
32. Riad M, Zimmer L, Rbah L, Watkins KC, Hamon M, Descarries L. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci. 2004;24(23):5420-5426.
33. Sibon I, Benkelfat C, Gravel P, et al. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. Biol Psychiatry. 2008;63(12):1135-1140.
34. Della Rocca GJ, Mukhin YV, Garnovskaya MN, et al. Serotonin 5-HT1A receptormediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J Biol Chem. 1999;274(8):4749-4753.
35. Renner U, Glebov K, Lang T, et al. Localization of the mouse 5-hydroxytryptamine(1A) receptor in lipid microdomains depends on its palmitoylation and is involved in receptor-mediated signaling. Mol Pharmacol. 2007;72(3):502-513.
36. Bouaziz E, Emerit MB, Vodjdani G, et al. Neuronal phenotype dependency of agonistinduced internalization of the 5-HT1A serotonin receptor. J Neurosci. 2014;34(1):282-294.
37. Kurisu J, Fukuda T, Yokoyama S, Hirano T, Kengaku M. Polarized targeting of DNER into dendritic plasma membrane in hippocampal neurons depends on endocytosis. J Neurochem. 2010;113(6):1598-1610.
38. Miquel MC, Doucet E, Boni C, et al. Central serotonin1A receptors: respective distribution of encoding mRNA, receptor protein and binding sites by in situ hybridization histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochem Int. 1991;19:453-465.
39. Boschert U, Amara DA, Segu L, Hen R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience. 1994;58(1):167-182.
40. Langlois X, ElMestikawy S, Arpin M, Triller A, Hamon M, Darmon M. Differential addressing of 5-HT1A and 5-HT1B receptors in transfected LLC-PK1 epithelial cells: a model of receptor targeting in neurons. Neuroscience. 1996;74(2):297-302.
41. Ghavami A, Stark KL, Jareb M, Ramboz S, Segu L, Hen R. Differential addressing of 5-HT1A and 5-HT1B receptors in epithelial cells and neurons. J Cell Sci. 1999;112(Pt 6):967-976.
42. Darmon M, Langlois X, Suffisseau L, Fattaccini CM, Hamon M. Differential membrane targeting and pharmacological characterization of chimeras of rat serotonin 5-HT1A and 5-HT1B receptors expressed in epithelial LLC-PK1 cells. J Neurochem. 1998;71(6):2294-2303.
43. Jolimay N, Franck L, Langlois X, Hamon M, Darmon M. Dominant role of the cytosolic C-terminal domain of the rat 5-HT1B receptor in axonal-apical targeting. J Neurosci. 2000;20(24):9111-9118.
44. Carrel D, Simon A, Emerit MB, et al. Axonal targeting of the 5-HT1B serotonin receptor relies on structure-specific constitutive activation. Traffic. 2011; 12(11):1501-1520.
45. Carrel D, Masson J, Al Awabdh S, et al. Targeting of the 5-HT1A serotonin receptor to neuronal dendrites is mediated by Yif1B. J Neurosci. 2008;28(32):8063-8073.
46. Matern H, Yang X, Andrulis E, Sternglanz R, Trepte HH, Gallwitz D. A novel Golgi membrane protein is part of a GTPase-binding protein complex involved in vesicle targeting. EMBO J. 2000;19(17):4485-4492.
47. Al Awabdh S, Miserey-Lenkei S, Bouceba T, et al. A new vesicular scaffolding complex mediates the G-protein-coupled 5-HT1A receptor targeting to neuronal dendrites. J Neurosci. 2012;32(41):14227-14241.
48. Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res. 2008;195(1):198-213.
49. Malleret G, Hen R, Guillou JL, Segu L, Buhot MC. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J Neurosci. 1999;19(14):6157-6168.
50. Leterrier C, Laine J, Darmon M, Boudin H, Rossier J, Lenkei Z. Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. J Neurosci. 2006;26(12):3141-3153.
51. Hauri HP, Matter K. Protein traffic in intestinal epithelial cells. Semin Cell Biol. 1991;2(6):355-364.
52. Svenningsson P, Chergui K, Rachleff I, et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science. 2006;311(5757):77-80.
53. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta. 1999;1450(3):191-231.
54. Zhang X, Andren PE, Greengard P, Svenningsson P. Evidence for a role of the 5-HT1B receptor and its adaptor protein, p11, in L-DOPA treatment of an animal model of Parkinsonism. Proc Natl Acad Sci USA. 2008;105(6):2163-2168.
55. Eriksson TM, Alvarsson A, Stan TL, et al. Bidirectional regulation of emotional memory by 5-HT1B receptors involves hippocampal p11. Mol Psychiatry. 2013;18(10):1096-1105.
56. Lee SP, Xie Z, Varghese G, Nguyen T, O'Dowd BF, George SR. Oligomerization of dopamine and serotonin receptors. Neuropsychopharmacology. 2000;23(4 suppl): S32-S40.
57. Salim K, Fenton T, Bacha J, et al. Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. J Biol Chem. 2002;277(18):15482-15485.
58. Conn PJ, Sanders-Bush E. Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology. 1984;23(8): 993-996.
59. Masson J, Emerit MB, Hamon M, Darmon M. Serotonergic signaling: multiple effectors and pleiotropic effects. WIREs Membr Transp Signal. 2012;1(6):685-713.
60. Hanley NR, Hensler JG. Mechanisms of ligand-induced desensitization of the 5-hydroxytryptamine(2A) receptor. J Pharmacol Exp Ther. 2002;300(2):468-477.
61. Willins DL, Alsayegh L, Berry SA, et al. Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo. Ann N Y Acad Sci. 1998;861:121-127.
62. Berry SA, Shah MC, Khan N, Roth BL. Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro. Mol Pharmacol. 1996;50(2):306-313.
63. Bhattacharyya S, Puri S, Miledi R, Panicker MM. Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms. Proc Natl Acad Sci USA. 2002;99(22):14470-14475.
64. Willins DL, Berry SA, Alsayegh L, et al. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience. 1999;91(2):599-606.
65. Gelber EI, Kroeze WK, Willins DL, et al. Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: the third intracellular loop is alphahelical and binds purified arrestins. J Neurochem. 1999;72(5):2206-2214.
66. Schmid CL, Raehal KM, Bohn LM. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc Natl Acad Sci USA. 2008;105(3):1079-1084.
67. Bhatnagar A, Willins DL, Gray JA, Woods J, Benovic JL, Roth BL. The dynamindependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis. J Biol Chem. 2001;276(11):8269-8277.
68. Bhattacharya A, Sankar S, Panicker MM. Differences in the C-terminus contribute to variations in trafficking between rat and human 5-HT(2A) receptor isoforms: identification of a primate-specific tripeptide ASK motif that confers GRK-2 and beta arrestin-2 interactions. J Neurochem. 2010;112(3):723-732.
69. Xia Z, Gray JA, Compton-Toth BA, Roth BL. A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction. J Biol Chem. 2003;278(24):21901-21908.
70. Xia Z, Hufeisen SJ, Gray JA, Roth BL. The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro. Neuroscience. 2003;122(4):907-920.
71. Pichon X, Wattiez AS, Becamel C, et al. Disrupting 5-HT(2A) receptor/PDZ protein interactions reduces hyperalgesia and enhances SSRI efficacy in neuropathic pain. Mol Ther. 2010;18(8):1462-1470.
72. Wattiez AS, Pichon X, Dupuis A, et al. Disruption of 5-HT2A receptor-PDZ protein interactions alleviates mechanical hypersensitivity in carrageenan-induced inflammation in rats. PLoS One. 2013;8(9):e74661.
73. Bhatnagar A, Sheffler DJ, Kroeze WK, Compton-Toth B, Roth BL. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J Biol Chem. 2004;279(33):34614-34623.
74. Allen JA, Yadav PN, Roth BL. Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases. Neuropharmacology. 2008;55(6):961-968.
75. Baldys A, Raymond JR. Role of c-Cbl carboxyl terminus in serotonin 5-HT2A receptor recycling and resensitization. J Biol Chem. 2011;286(28):24656-24665.
76. Foguet M, Hartikka JA, Schmuck K, Lübbert H. Long-term regulation of serotonergic activity in the rat via activation of protein kinase A. EMBO J. 1993;12:903-910.
77. Kursar JD, Nelson DL, Wainscott DB, Cohen ML, Baez M. Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus. Mol Pharmacol. 1992;42(4):549-557.
78. Porter RH, Malcolm CS, Allen NH, Lamb H, Revell DF, Sheardown MJ. Agonistinduced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells. Biochem Pharmacol. 2001;62(4):431-438.
79. Janoshazi A, Deraet M, Callebert J, et al. Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors. Mol Pharmacol. 2007;71(6):1463-1474.
80. Deraet M, Manivet P, Janoshazi A, et al. The natural mutation encoding a C terminustruncated 5-hydroxytryptamine 2B receptor is a gain of proliferative functions. Mol Pharmacol. 2005;67(4):983-991.
81. Sanders-Bush E, Breeding M. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus. J Pharmacol Exp Ther. 1988;247(1):169-173.
82. Miller KJ. Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity. Mol Interv. 2005;5(5):282-291.
83. Rosenzweig-Lipson S. New horizons for selective 5-HT2C receptor ligands in psychiatric/ neurological disorders. Neuropsychopharmacology. 2011;36(1):363-364.
84. Masson J, Bouaziz E, Emerit MB, Hamon M, Darmon M. Brain region-dependent internalisation of 5-HT1A receptors: molecular mechanisms and relevance for antidepressant therapy. Eur Neuropsychopharmacol. 2012;22:S128.
85. Schlag BD, Lou Z, Fennell M, Dunlop J. Ligand dependency of 5-hydroxytryptamine 2C receptor internalization. J Pharmacol Exp Ther. 2004;310(3):865-870.
86. Magalhaes AC, Holmes KD, Dale LB, et al. CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nat Neurosci. 2010;13(5):622-629.
87. Toth DJ, Toth JT, Gulyas G, et al. Acute depletion of plasma membrane phosphatidylinositol 4,5-bisphosphate impairs specific steps in endocytosis of the G-protein-coupled receptor. J Cell Sci. 2012;125(pt 9):2185-2197.
88. Chanrion B, Mannoury la Cour C, Gavarini S, et al. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction. Mol Pharmacol. 2008;73(3):748-757.
89. Labasque M, Reiter E, Becamel C, Bockaert J, Marin P. Physical interaction of calmodulin with the 5-HT2C receptor C-terminus is essential for G protein-independent, arrestin-dependent, receptor signaling. Mol Biol Cell. 2008;19:4640-4650.
90. Labasque M, Meffre J, Carrat G, Becamel C, Bockaert J, Marin P. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants. Mol Pharmacol. 2010;78(5):818-826.
91. Marion S, Weiner DM, Caron MG. RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem. 2004; 279(4):2945-2954.
92. Werry TD, Loiacono R, Sexton PM, Christopoulos A. RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol Ther. 2008;119(1):7-23.
93. Kawahara Y, Grimberg A, Teegarden S, et al. Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J Neurosci. 2008;28(48):12834-12844.
94. Martin CB, Ramond F, Farrington DT, et al. RNA splicing and editing modulation of 5-HT(2C) receptor function: relevance to anxiety and aggression in VGV mice. Mol Psychiatry. 2013;18(6):656-665.
95. Schellekens H, van Oeffelen WE, Dinan TG, Cryan JF. Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling. J Biol Chem. 2013;288(1):181-191.
96. Gavarini S, Becamel C, Altier C, et al. Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability. Mol Biol Cell. 2006;17(11):4619-4631.
97. Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol. 1988;34(6):880-887.
98. Pindon A, van Hecke G, van Gompel P, Lesage AS, Leysen JE, Jurzak M. Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins. Mol Pharmacol. 2002; 61(1):85-96.
99. Pindon A, Van Hecke G, Josson K, et al. Internalization of human 5-HT4a and 5-HT4b receptors is splice variant dependent. Biosci Rep. 2004;24(3):215-223.
100. Mialet J, Fischmeister R, Lezoualc'h F. Characterization of human 5-HT4(d) receptor desensitization in CHO cells. Br J Pharmacol. 2003;138(3):445-452.
101. Barthet G, Gaven F, Framery B, et al. Uncoupling and endocytosis of 5-hydroxytryptamine 4 receptors. Distinct molecular events with different GRK2 requirements. J Biol Chem. 2005;280(30):27924-27934.
102. Warner-Schmidt JL, Flajolet M, Maller A, et al. Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci. 2009;29(6):1937-1946.
103. Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum. Neuropharmacology. 2011;61(3):442-450.
104. Ruat M, Traiffort E, Arrang JM, et al. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun. 1993;193(1):268-276.
105. Gerard C, Martres MP, Lefevre K, et al. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res. 1997; 746(1-2):207-219.
106. Sleight AJ, Boess FG, Bos M, Bourson A. The putative 5-ht6 receptor: localization and function. Ann N Y Acad Sci. 1998;861:91-96.
107. Brailov I, Bancila M, Brisorgueil MJ, Miquel MC, Hamon M, Verge D. Localization of 5-HT(6) receptors at the plasma membrane of neuronal cilia in the rat brain. Brain Res. 2000;872(1-2):271-275.
108. Davenport JR, Yoder BK. An incredible decade for the primary cilium: a look at a once-forgotten organelle. Am J Physiol Renal Physiol. 2005;289(6):F1159-F1169.
109. Ikeuchi Y, de la Torre-Ubieta L, Matsuda T, Steen H, Okazawa H, Bonni A. The XLID protein PQBP1 and the GTPase Dynamin 2 define a signaling link that orchestrates ciliary morphogenesis in postmitotic neurons. Cell Rep. 2013;4(5):879-889.
110. Guadiana SM, Semple-Rowland S, Daroszewski D, et al. Arborization of dendrites by developing neocortical neurons is dependent on primary cilia and type 3 adenylyl cyclase. J Neurosci. 2013;33(6):2626-2638.
111. Mahjoub MR, Stearns T. Supernumerary centrosomes nucleate extra cilia and compromise primary cilium signaling. Curr Biol. 2012;22(17):1628-1634.
112. Kim SH, Kim DH, Lee KH, et al. Direct interaction and functional coupling between human 5-HT6 receptor and the light chain 1 subunit of the microtubule-associated protein 1B (MAP1B-LC1). PLoS One. 2014;9(3):e91402.
113. Vanhoenacker P, Haegeman G, Leysen JE. 5-HT7 receptors: current knowledge and future prospects. Trends Pharmacol Sci. 2000;21(2):70-77.
114. Hedlund PB, Sutcliffe JG. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci. 2004;25(9):481-486.
115. Inoue M, Kitazawa T, Cao J, Taneike T. 5-HT7 receptor-mediated relaxation of the oviduct in nonpregnant proestrus pigs. Eur J Pharmacol. 2003;461(2-3):207-218.
116. Guthrie CR, Murray AT, Franklin AA, Hamblin MW. Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms. J Pharmacol Exp Ther. 2005;313(3):1003-1010.
117. Renner U, Zeug A, Woehler A, et al. Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. J Cell Sci. 2012;125(pt 10):2486-2499.